Company intelligence / Profile preview

Resonance Labs

San Francisco, California, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Resonance is a biotechnology company building a high-throughput proteomics platform designed to serve as a search engine for biology. By combining advanced mass spectrometry with machine learning, the company maps the human proteome at unprecedented scale and speed to identify novel drug targets and biomarkers. Resonance focuses on decoding complex biological states to accelerate the discovery of therapeutics for aging-related and metabolic diseases. The company's technology aims to transform static biological data into dynamic, searchable insights for drug development.

Therapeutic areas: OncologyOtherMetabolic Disorders
Modalities: Small moleculeProtein
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Resonance Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resonance Labs.

Explore the full profile